A clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for CNS-mediated conditions
Noema Pharma is a pioneering biotechnology company focused on developing a portfolio of disease-transforming therapeutics for conditions mediated by the central nervous system (CNS). Dedicated to addressing unmet needs, Noema Pharma is committed to researching and developing novel therapies that alleviate the most disabling symptoms associated with orphan conditions affecting the brain and nervous system.
Based in Basel, CH, Noema Pharma leverages its expertise and innovative approach to make a significant impact on patient lives. The company’s commitment to groundbreaking research positions Noema Pharma as a key player in the biotechnology sector, driving advancements in CNS therapeutics. Noema Pharma aims to improve patient outcomes and quality of life through its focused and dedicated approach.
Noema Pharma invites you to learn more about its mission and ongoing projects. We are actively expanding our reach and impact in the biotechnology space. To further enhance your presence on our platform, we encourage the management of Noema Pharma to create a customized and exclusive company showcase and product listing, highlighting your unique contributions to the industry.
Other organizations in the same industry
This company is also known as